PRESS RELEASE published on 05/08/2023 at 14:30, 1 year 6 months ago Jaguar Health to Hold Investor Webcast Monday, May 15th at 8:30 AM EDT Regarding Q1 2023 Financials & Corporate Updates
PRESS RELEASE published on 05/05/2023 at 22:15, 1 year 6 months ago Jaguar Health Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
PRESS RELEASE published on 05/01/2023 at 14:30, 1 year 6 months ago Napo Therapeutics Sponsoring Pediatric Gastroenterology Conference: Elite Ped-GI Congress in Abu Dhabi
PRESS RELEASE published on 04/27/2023 at 14:30, 1 year 6 months ago U.S. Veterinary Oncologists Participating in a New Survey Prefer Canalevia-CA1 Over the Current Standard of Care
PRESS RELEASE published on 04/11/2023 at 14:30, 1 year 7 months ago Patient Enrollment Surpasses 90% in Jaguar Health's Pivotal Phase 3 OnTarget Trial of Crofelemer for Cancer Therapy-Related Diarrhea
PRESS RELEASE published on 04/06/2023 at 14:30, 1 year 7 months ago Jaguar Health Provides Update on Monitoring Trading Activity to Identify Possible Illegal Short Selling
PRESS RELEASE published on 03/30/2023 at 14:30, 1 year 7 months ago Jaguar Animal Health Exhibiting at Veterinary Cancer Society Collaborative Conference for Canalevia-CA1, the Company's FDA Conditionally Approved Drug for Chemotherapy-Induced Diarrhea (CID) in Dogs
PRESS RELEASE published on 03/27/2023 at 13:00, 1 year 7 months ago Jaguar Health Reports 2022 Financial Results - Prescription Revenues up 179% to $11.9 Million
PRESS RELEASE published on 03/24/2023 at 18:30, 1 year 8 months ago Jaguar Health Announces Time Change for March 27th Investor Webcast to 8:00 AM EDT
PRESS RELEASE published on 03/23/2023 at 13:30, 1 year 8 months ago Leading Cancer Patient Advocate Kelly Shanahan, M.D., Joins Jaguar Health's Scientific Advisory Board
Published on 11/25/2024 at 04:00, 4 hours 27 minutes ago Tanzania Safaris Unveils New Luxury Adventure Packages for 2025
Published on 11/22/2024 at 23:55, 2 days 8 hours ago Boron One Announces Early Warrant Exercise Incentive Program
Published on 11/22/2024 at 23:30, 2 days 8 hours ago Electric Royalties Enters Into Definitive Agreement to Acquire 0.75% Gross Revenue Royalty on Producing Punitaqui Copper Mine in Chile
Published on 11/22/2024 at 23:05, 2 days 9 hours ago Nexa Resources Announces Closing Transaction of Pukaqaqa Project Sale to Olympic
Published on 11/25/2024 at 08:15, 12 minutes ago EQS-Adhoc: Airbus SE: Airbus launches second tranche of previously-announced limited share buyback programme
Published on 11/25/2024 at 08:00, 27 minutes ago Dalata Hotel Group PLC: POS-Transaction in Own Shares
Published on 11/24/2024 at 19:16, 13 hours 11 minutes ago EQS-Adhoc: RENK Group AG: Termination of mandate of CEO Susanne Wiegand and appointment of Dr. Alexander Sagel as CEO
Published on 11/25/2024 at 08:00, 27 minutes ago EURAZEO RAISES A €180 MILLION CONTINUATION FUND TO SUPPORT I-TRACING AND ITS MANAGEMENT TEAM IN THE NEXT PHASE OF GROWTH
Published on 11/21/2024 at 06:58, 4 days 1 hour ago Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/20/2024 at 19:20, 4 days 13 hours ago Peugeot Invest Board of Directors to evolve following the May 2025 Annual General Meeting
Published on 11/20/2024 at 17:45, 4 days 14 hours ago MEDESIS PHARMA HAS COMPLETED ITS CLINICAL STUDY FOR THE TREATMENT OF ALZHEIMER'S DISEASE WITH NANOLITHIUM
